GLOBAL ANNOUNCES FALL 2025 PREMIERE DATES FEATURING THREE NEW SERIES AND MORE TOP 20 RETURNING HITS THAN ANY OTHER NETWORK*

Stock Information for Jounce Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Jounce Therapeutics Inc.

CORUS ENTERTAINMENT ANNOUNCES RECEIPT OF INTERIM ORDER IN RESPECT OF RECAPITALIZATION TRANSACTION
GLOBAL'S DYNAMIC WINTER 2026 SCHEDULE DELIVERS NEW SERIES FROM EVERY GENRE INCLUDING HARLAN COBEN'S FINAL TWIST, CIA, Y: MARSHALS AND AMERICA'S CULINARY CUP ALONGSIDE SURVIVOR SEASON 50
STAR-STUDDED CASTS, COMPELLING STORYTELLING, AND POPULAR RETURNING SEASONS ANCHOR SHOWCASE AND W NETWORK'S MIDSEASON SCHEDULES
CORUS' W NETWORK SLEIGHS THE SEASON WITH 20 RECORD-BREAKING SPONSORSHIPS FOR HALLMARK CHANNEL'S COUNTDOWN TO CHRISTMAS
Canadian Investment Regulatory Organization Trade Resumption - CJR.B
Canadian Investment Regulatory Organization Trading Halt - CJR.B
CORUS ENTERTAINMENT ANNOUNCES RECAPITALIZATION TRANSACTION
CORUS ENTERTAINMENT ANNOUNCES FISCAL 2025 FOURTH QUARTER AND YEAR END RESULTS

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.